Abstract
Solid phase Luminex® and flow cytometric single antigen bead assays offer exquisite sensitivity and specificity for HLA antibody detection. Unlike the historical complement-dependent cytotoxicity (CDC) method, these assays do not distinguish complement fixing from non-complement fixing antibody, the former of which are considered the most clinically relevant in the peri-transplant period. This chapter describes a novel solid phase C1q binding assay to distinguish HLA antibodies that can bind the first component of complement (C1q). These antibodies have the capacity to initiate the complement cascade irrespective of whether that actually occurs. The C1q assay detects many more complement fixing antibodies than are observed by the less sensitive and less specific CDC assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Patel R, Terasaki PI (1969) Significance of positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739
Pei R, Lee JH, Chen T et al (1999) Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 60:1293–1302
Pei R, Lee JH, Shih NJ et al (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75:43–49
Bartel G, Wahrmann M, Exner M et al (2008) In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant 8:41–49
Smith JD, Hamour IM, Banner NR et al (2007) C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant 7:2809–2815
Wahrmann M, Bartel G, Exner M et al (2009) Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 22:982–989
Wahrmann M, Exner M, Haidbauer B et al (2005) [C4d]FlowPRA screening – a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Hum Immunol 66:526–534
Wahrmann M, Exner M, Regele H et al (2003) Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 275:149–160
Chen G, Sequeira F, Tyan DB (2011) Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 72:849–858
Heeger PS (2010) A complementary approach to treating antibody-mediated transplant rejection. Kidney Int 78:125–127
Chin C, Chen G, Sequeria F et al (2011) Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 30:158–163
Sutherland SM, Chen G, Sequeira FA et al (2012) Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 16:12–17
Yabu JM, Higgins JP, Chen G et al (2011) C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 91:342–347
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Chen, G., Tyan, D.B. (2013). C1q Assay for the Detection of Complement Fixing Antibody to HLA Antigens. In: Zachary, A., Leffell, M. (eds) Transplantation Immunology. Methods in Molecular Biology, vol 1034. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-493-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-62703-493-7_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-492-0
Online ISBN: 978-1-62703-493-7
eBook Packages: Springer Protocols